TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Afroza, Halima
Altri autori:	Talukder, Mesbah
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Psoriasis Alopecia TNF-α inhibitor FAERS ROR Disproportionality analysis
Accesso online:	http://hdl.handle.net/10361/22075

Documenti analoghi

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
di: Islam, Nahidul
Pubblicazione: (2023)

Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
di: Tamanna, Shams Tahsin
Pubblicazione: (2020)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
di: Islam, S.M. Zahidul
Pubblicazione: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
di: Khandker, Tahia Anjum
Pubblicazione: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
di: Akter, Anika
Pubblicazione: (2022)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
di: Meem, Manila
Pubblicazione: (2023)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
di: Tabassum, Azwada
Pubblicazione: (2021)

Identification of FAP inhibitors using in silico simulation study
di: Deeba, Maliha Tasnim
Pubblicazione: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
di: Moya, Amena Khatun
Pubblicazione: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
di: Onanna, Kazi
Pubblicazione: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
di: Jahan, Safrin
Pubblicazione: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
di: Islam, Saidul
Pubblicazione: (2022)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
di: Bishakha, Adwiza Chakraborty
Pubblicazione: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
di: Karim, Azrin
Pubblicazione: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
di: Oshin, Sadia Afrin
Pubblicazione: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
di: Mahin, Md. Tamjidur Rahman
Pubblicazione: (2024)

Female Alopecia
di: TrÃ¼eb
Pubblicazione: (2013)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
di: Khan, Muidul Hasan
Pubblicazione: (2024)

Induced pluripotent stem cells: a novel tool for modelling and treating Parkinson’s disease
di: Tanin, Nahid Sultana
Pubblicazione: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
di: Sorno, Rubina Haque
Pubblicazione: (2024)

Detection of skin diseases using deep learning
di: Shodoy, Masuk Ur Rahman
Pubblicazione: (2024)

Pharmacoepidemiology and Pharmacovigilance

Synthesis and sar o acne medication
di: Naureen, Tasnia
Pubblicazione: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
di: Fred, Namanda Rogers
Pubblicazione: (2021)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
di: Mehreen, Elnaj
Pubblicazione: (2021)

HPLC method development for the analysis of linagliptin
di: Mimiya, Ruhani Amrin
Pubblicazione: (2020)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Importance of biologics in rheumatoid arthritis management
di: Riyadh, S. M.
Pubblicazione: (2022)

Pharmacovigilance in the European Union
di: Kaeding
Pubblicazione: (2017)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
di: Ratu, Tabassum
Pubblicazione: (2024)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
di: Nour, Sabrina
Pubblicazione: (2019)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
di: Emon, Kamrul Hasan
Pubblicazione: (2022)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
di: Rahman, Towsifur
Pubblicazione: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
di: Mirza, Maisa Tasnim
Pubblicazione: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
di: Rahman, Ahadina
Pubblicazione: (2018)